Showing results (111-120 of 203) with videos related to

Sort By:
Pageof 21
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Preliminary results of a phase II trial for the treatment of metastatic breast cancer with 5-fluorouracil and leucovorinC J Allegra, B A Chabner, P W Sholar, et al.
The Oncologist|May 25, 1999
A staff dialogue on aggressive palliative treatment demanded by a terminally ill patient: psychosocial issues faced by patients, their families, and caregiversK C Lintz, R T Penson, N Cassem, et al.
The Oncologist|July 8, 1999
A staff dialogue on do not resuscitate orders: psychosocial issues faced by patients, their families, and caregiversE M O'Shea, R T Penson, T A Stern, et al.
The British Journal of Cancer. Supplement|March 1, 1975
Results of combination chemotherapy of non-Hodgkin's lymphomaP S Schein, B A Chabner, G P Canellos, et al.
The Journal of Biological Chemistry|May 25, 1988
Identification and biochemical properties of 10-formyldihydrofolate, a novel folate found in methotrexate-treated cellsJ Baram, B A Chabner, J C Drake, et al.
The Journal of Experimental Medicine|March 1, 1987
Activity of antifolates against Pneumocystis carinii dihydrofolate reductase and identification of a potent new agentC J Allegra, J A Kovacs, J C Drake, et al.
Seminars in Oncology|December 1, 1992
Recent National Cancer Institute lymphoma trials of etoposide-containing combination chemotherapyW J Urba, W H Wilson, P L Duffey, et al.
Cancer Research|July 15, 1994
Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosoureaJ Plowman, W R Waud, A D Koutsoukos, et al.
The British Journal of Cancer. Supplement|March 1, 1975
Therapy of advanced lymphocytic lymphoma a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapyG P Canellos, V T DeVita, R C Young, et al.
Cancer Research|October 10, 1998
Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitorR Z Orlowski, J R Eswara, A Lafond-Walker, et al.
Pageof 21